54,763 followers
RT @ABsteward: NEW 🔥 in @@InfectDis_Ther Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organ…
622 followers
Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms. https://t.co/xSSTklP9RD #cre #crkp #AMR
2,049 followers
RT @ABsteward: NEW 🔥 in @@InfectDis_Ther Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organ…
1,095 followers
RT @InfectDis_Ther: Read the latest Editorial from our Editor-in-Chief Dr Michael Rybak @IDpharmresearch: "Pathogen-Specific Clinical Trial…
159 followers
RT @ABsteward: NEW 🔥 in @@InfectDis_Ther Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organ…
117 followers
RT @ABsteward: NEW 🔥 in @@InfectDis_Ther Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organ…
2,849 followers
RT @ABsteward: NEW 🔥 in @@InfectDis_Ther Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organ…
484 followers
RT @ABsteward: NEW 🔥 in @@InfectDis_Ther Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organ…
1,307 followers
RT @ABsteward: NEW 🔥 in @@InfectDis_Ther Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organ…
54,763 followers
NEW 🔥 in @@InfectDis_Ther Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms. A must read editorial for TANGO II trial by @canuckpharmID @IDpharmresearch #IDWeek2018 https://t.co/MhJmOWdXRh https://t.co/
2,049 followers
Read the latest Editorial from our Editor-in-Chief Dr Michael Rybak @IDpharmresearch: "Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms". Full article here: https://t.co/9ljre7wjQB